Bioventix PLC
LSE:BVXP
Bioventix PLC
LSE:BVXP
Price:
4 375 GBX
Market Closed
Updated:
May 17, 2024
Bioventix PLC
Gross Profit
|
Bioventix PLC
Gross Profit Peer Comparison
Comparables:
CNTA
AUTL
BCYC
IMCR
GNS
Competitive Gross Profit Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Gross Profit | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Bioventix PLC
LSE:BVXP
|
Gross Profit
£12.7m
|
CAGR 3-Years
11%
|
CAGR 5-Years
10%
|
CAGR 10-Years
16%
|
|
|
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Autolus Therapeutics PLC
NASDAQ:AUTL
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bicycle Therapeutics PLC
NASDAQ:BCYC
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Immunocore Holdings PLC
NASDAQ:IMCR
|
Gross Profit
£248.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Genus PLC
LSE:GNS
|
Gross Profit
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Bioventix PLC's Gross Profit?
Gross Profit
12.7m
GBP
12.7m
GBP
Based on the financial report for Dec 31, 2023, Bioventix PLC's Gross Profit amounts to 12.7m GBP.
What is Bioventix PLC's Gross Profit growth rate?
Gross Profit CAGR 10Y
16%
16%
Over the last year, the Gross Profit growth was 5%. The average annual Gross Profit growth rates for Bioventix PLC have been 11% over the past three years , 10% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
